跳转至内容
Merck
CN
  • Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization.

Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization.

Autophagy (2015-02-05)
Kun Liu, Enpeng Zhao, Ghulam Ilyas, Gadi Lalazar, Yu Lin, Muhammad Haseeb, Kathryn E Tanaka, Mark J Czaja
摘要

Recent evidence that excessive lipid accumulation can decrease cellular levels of autophagy and that autophagy regulates immune responsiveness suggested that impaired macrophage autophagy may promote the increased innate immune activation that underlies obesity. Primary bone marrow-derived macrophages (BMDM) and peritoneal macrophages from high-fat diet (HFD)-fed mice had decreased levels of autophagic flux indicating a generalized impairment of macrophage autophagy in obese mice. To assess the effects of decreased macrophage autophagy on inflammation, mice with a Lyz2-Cre-mediated knockout of Atg5 in macrophages were fed a HFD and treated with low-dose lipopolysaccharide (LPS). Knockout mice developed systemic and hepatic inflammation with HFD feeding and LPS. This effect was liver specific as knockout mice did not have increased adipose tissue inflammation. The mechanism by which the loss of autophagy promoted inflammation was through the regulation of macrophage polarization. BMDM and Kupffer cells from knockout mice exhibited abnormalities in polarization with both increased proinflammatory M1 and decreased anti-inflammatory M2 polarization as determined by measures of genes and proteins. The heightened hepatic inflammatory response in HFD-fed, LPS-treated knockout mice led to liver injury without affecting steatosis. These findings demonstrate that autophagy has a critical regulatory function in macrophage polarization that downregulates inflammation. Defects in macrophage autophagy may underlie inflammatory disease states such as the decrease in macrophage autophagy with obesity that leads to hepatic inflammation and the progression to liver injury.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
HEPES, ≥99.5% (titration)
Sigma-Aldrich
2-甲基丁烷, ReagentPlus®, ≥99%
Sigma-Aldrich
HEPES, BioPerformance Certified, ≥99.5% (titration), suitable for cell culture
Sigma-Aldrich
MEM 非必需氨基酸溶液 (100×), without L-glutamine, liquid, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
驴血清
Sigma-Aldrich
脂多糖 来源于大肠杆菌 0111:B4, γ-irradiated, BioXtra, suitable for cell culture
Sigma-Aldrich
氯化铵, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Rapamycin, ≥95% (HPLC), powder
Sigma-Aldrich
氯化铵, Molecular Biology, suitable for cell culture, ≥99.5%
Sigma-Aldrich
2-甲基丁烷, ReagentPlus®, ≥99%
Sigma-Aldrich
2-甲基丁烷, suitable for HPLC, ≥99.5%
Sigma-Aldrich
HEPES缓冲溶液, 1 M in H2O
Sigma-Aldrich
HEPES, BioUltra, Molecular Biology, ≥99.5% (T)
Sigma-Aldrich
氯化铵, 99.998% trace metals basis
Sigma-Aldrich
2-甲基丁烷, anhydrous, ≥99%
Sigma-Aldrich
HEPES, BioXtra, suitable for mouse embryo cell culture, ≥99.5% (titration)
Sigma-Aldrich
HEPES, BioXtra, pH 5.0-6.5 (1 M in H2O), ≥99.5% (titration)
Sigma-Aldrich
血清甘油三酯测定试剂盒, 1 kit sufficient for 250 tests
Supelco
氯化铵, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
氯化铵, 99.99% trace metals basis
Supelco
Rapamycin, VETRANAL®, analytical standard
Sigma-Aldrich
氯化铵, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, 99.5-100.5% (calc. to the dried substance)
Sigma-Aldrich
氯化铵, BioUltra, ≥99.5% (AT)
Sigma-Aldrich
HEPES, anhydrous, free-flowing, Redi-Dri, ≥99.5%
Millipore
布氏硫乙醇酸盐培养基, NutriSelect® Plus, powder, for bacteria, pack of 500 g, suitable for microbiology
Supelco
铵离子标准溶液, 1000 mg/kg N, analytical standard (for ion-selective electrodes)
Supelco
HEPES, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
2-甲基丁烷, analytical standard
Sigma-Aldrich
HEPES, Vetec, reagent grade, 99.5%
Sigma-Aldrich
氯化铵, tested according to Ph. Eur.